This inventor holds 9 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Burroughs Wellcome Co., Glaxo Wellcome Inc.. Active years: 1986-2006.
Location History:
- Raleigh, NC (US) (1986 - 2005)
- Durham, NC (US) (2006)
Company Filing History:
4 out of 2,198 
3 out of 521 
2 out of 281 
Years Active: 1986-2006
Title: Gary Keith Smith: Innovator in Viral Proteins and Pharmaceutical Formulations
Introduction
Gary Keith Smith is a notable inventor based in Raleigh, NC (US), recognized for his contributions to the field of viral proteins and pharmaceutical formulations. With a total of 9 patents to his name, Smith has made significant strides in the scientific community.
Latest Patents
Among his latest patents, Smith has developed innovative solutions such as Bunyaviridal reaper proteins and their uses. These viral proteins exhibit sequence and functional similarities to the Drosophila cell death protein known as Reaper, which plays a crucial role in the apoptotic pathway. Additionally, he has patented methods utilizing these viral proteins and the nucleotides encoding them. Another significant patent involves the combination of benzoquinazoline antifolates and protecting agents. This patent describes the use of a protecting agent, such as a folate derivative like folic acid or leucovorin, in conjunction with a non-competitive folic acid analogue, specifically benzoquinazoline derivatives. This combination aims to reduce the side effects associated with administering such non-competitive folic acid analogues, along with pharmaceutical formulations comprising these combinations.
Career Highlights
Throughout his career, Smith has worked with prominent companies, including SmithKline Beecham Corporation and Burroughs Wellcome Co. His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Smith has collaborated with notable coworkers, including Eric C. Bigham and Arthur Koch, further enhancing his contributions to the field.
Conclusion
Gary Keith Smith's innovative work in viral proteins and pharmaceutical formulations has made a lasting impact on the scientific community. His patents reflect a commitment to advancing medical science and improving patient outcomes.